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The surface membranes of cells infected with herpes simplex virus type 1 (HSV-l), 
strain KOS, contain three principal glycoproteins, gC (apparent Mr 129k), gB (apparent 
M, 120k), and gD (apparent M, 58k). Infections carried out in the presence of the gly- 
cosylation inhibitor 2-deoxy-D-glucose result in the loss of the mature species with the 
concurrent appearance of lower-molecular-weight polypeptides which are presumably 
partially glycosylated forms of the fully processed glycoproteins. Specific immunopre- 
cipitation of radiolabeled cytoplasmic extracts of 2-deoxy-u-glucose-inhibited infections 
identified partially glycosylated proteins designated DG92, DG88, and DG53, which are 
antigenically related to the corresponding mature forms gB, gC, and gD. Cell surface 
radioiodination, in combination with specific immunoprecipitation, revealed that DG88 
and DG53 were the principal species transported to the cell surface in 2-deoxy-n-glucose- 
inhibited infections. DG92 was readily detected in the cytoplasm but not on the plasma 
membrane. Cells infected with the KOS mutant, syn LD70, did not synthesize glycoprotein 
gC. In glycosylation-inhibited syn LD70 infections, DG88 was not detected in either the 
cytoplasm or plasma membrane, demonstrating a genetic relationship between DG88 and 
gC. Polyclonal and monoclonal antibodies directed against the glyeoproteins gC, gB, and 
gD sensitized infected cells to complement-mediated immune cytolysis. Cells infected in 
the presence of the inhibitor were sensitized to lysis only by antibody specific for gC and 
gD. The glycosylation-inhibited cells were insensitive to immunolysis by anti-gB mono- 
clonal antibody. These findings confirm that the glycosylation-deficient forms of gC and 
gD, but not gB reach the cell surface in the presence of inhibitor and that the inhibitor- 
induced alterations in glycosylation do not cause a complete loss of antigenicity. Inoc- 
ulation of mice with syngeneic 3T3 cells infected in the presence or absence of inhibitor- 
induced cytolytic and neutralizing antibody. A major portion of the cytolytic antibody 
was directed against gC, but anti-& antibody appeared to play a minor role in virus 
neutralization. While the serum induced by the control infected cells contained precip- 
itating antibodies for gC, gB, and gD, the serum derived from mice inoculated with 
inhibitor-treated infected cells had only weak immunoprecipitating activity against gB. 
Together, these findings have identified partially glycosylated forms of the major HSV 
glycoproteins and show that complete glycosylation is not required for transport of some 
of these partially glycosylated polypeptides to the cell surface. Moreover, complete gly- 
cosylation of the glycopeptides is not essential for maintenance of antigenicity or im- 
munogenieity, indicating that at least some determinants recognized by antibodies di- 
rected against the mature glycoproteins are not affected by Z-deoxy-D-glucose-induced 
carbohydrate alterations. 
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with corresponding apparent M, of 129k, 
126k, 80k, and 58k (Spear, 1976; Baucke and 
Spear, 1979; Eisenberg et al., 1979). Gly- 
coproteins gB and gD appear to be of the 
delayed early class, while gC may be of the 
late class of viral structural polypeptides 
synthesized in the course of infection (Ho- 
ness and Roizman, 19’74; Cohen et al., 1980; 
Marsden et al., 1976; Marsden et al., 1978; 
Peake et al., 1982; Balachandran et al., 
1982). Although initial studies indicated 
that gA and gB were antigenically distinct 
and separate gene products (Spear, 1976), 
recent evidence suggests that gA and gB 
are different forms of the same polypep- 
tide (Eberle and Courtney, 1980a; Person 
et al., 1982; Pereira et al., 1982). The HSV 
glycoproteins are transported to the sur- 
face membrane of infected cells early in 
the replication cycle, with maximum levels 
of accumulation occurring concurrently 
with the release of active virus (Glorioso 
and Smith, 1977; Norrild et al., 1978,198O). 
The HSV glycoproteins become incorpo- 
rated into the virion envelope (Spear and 
Roizman, 1972; Sarmiento et al., 1979) dur- 
ing the process of budding. Morphological 
evidence indicates that budding occurs at 
the inner lamella of the nuclear membrane 
(Morgan et al., 1959; Nii et al., 1968). 
The processing and intracellular trans- 
port of the HSV glycoproteins are still 
poorly understood. It is clear, however, that 
the glycoproteins are glycosylated through 
a series of successive intermediate stages 
detected by changes in apparent molecular 
weights in pulse-chase experiments (Ho- 
ness and Roizman, 1975; Spear, 1976; Cohen 
et al., 1980). Glycoprotein-specific antisera 
have been used to detect at least one par- 
tially glycosylated intermediate for each 
major glycoprotein species (Spear, 1976; 
Eisenberg et al., 1979; Eberle and Court- 
ney, 1980b). Based on studies of vesicular 
stomatitis virus (VSV) and Sindbis virus 
glycoprotein processing and intracellular 
transport (Hunt et al., 1978; Katz et al., 
1977; Knipe et al., 1977; Lodish et al., 1980; 
Rothman et al., 1980a, b), it might be as- 
sumed that the HSV glycoprotein messen- 
ger RNAs are translated on membrane- 
bound polysomes and that a mannose-rich 
oligosaccharide core becomes covalently 
attached to specific asparagine residues by 
rough endoplasmic reticulum-associated 
glycosyl transferases as a cotranslational 
event. Pizer et al. (1980) have provided ev- 
idence for N-linked mannose core glyco- 
sylation of glycoprotein gD. Further, car- 
bohydrate branch chain elongation by se- 
quential addition of N-acetylglucosamine, 
galatose, fucose, and sialic acid presum- 
ably occurs following transport of the gly- 
coproteins to the Golgi in clathrin-coated 
vesicles as is the case for VSV glycoprotein 
G (Tabas et al., 1979; Rothman and Fine, 
1980a, b). The mature glycoproteins are fi- 
nally inserted into the cell surface and 
possibly other membranes. It seems un- 
likely that fully mature species are trans- 
ported to the nuclear membrane, since the 
mature glycoproteins have not been de- 
tected in the nuclei of infected cells (Hol- 
land, 1978). In addition to N-linked oli- 
gosaccharides (Peake et al., 1982), evidence 
is accumulating that at least one HSV gly- 
coprotein, gC, is unique in that it contains 
both N-linked sugars and O-linked oligo- 
saccharides (Olofsson et al., 1981a). In this 
regard, gC has been shown to combine with 
Helix pomatia lectin indicating the pres- 
ence of an unusual sugar, N-acetylgalac- 
tosamine, which has been associated with 
O-linked branch chains in other viral gly- 
coproteins (Olofsson et al., 1981b). These 
findings raise the possibility that the HSV 
glycoproteins may be processed along more 
than one intracellular pathway. 
Glycosylation inhibitors have been used 
as an approach to identify partially gly- 
cosylated forms of the HSV glycoproteins 
and to detect differences in the intracel- 
lular movement and location of the drug- 
induced intermediates (Campadelli-Fiume 
et aZ., 1980; Courtney, 1976; Knowles and 
Person, 1976; Pizer et al., 1980; Peake et al., 
1982; Johnson and Spear, 1982; Norrild and 
Pedersen, 1982). Cells infected in the pres- 
ence of the sugar analog of mannose, 2- 
deoxy-D-glucose, synthesize partially gly- 
cosylated forms of the virus-specified gly- 
coproteins (Courtney, 1976; Knowles and 
Person, 1976). Although virions are pro- 
duced under these conditions, they are not 
infectious (Courtney, 1976). Other virion- 
directed cell surface changes, including cell 
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fusion, are also inhibited (Knowles and 
Person, 1976). Courtney et al. (1973) re- 
ported that 2-deoxy-D-glucose is incorpo- 
rated into the underglycosylated forms of 
the glycoproteins as a substitute for man- 
nose, preventing the addition of the com- 
plete mannose core and oligosaccharide 
chain elongation. Tunicamycin inhibits 
glycosylation of HSV glycoproteins by act- 
ing as an analog of UDP-N-acetyl glucos- 
amine (Pizer et al., 1980). This drug dis- 
rupts cotranslational glycosylation of the 
peptide backbone by interfering with for- 
mation of the dolicol pyrophosphate-N- 
acetyl glucosamine intermediate that nor- 
mally acts as a carrier for N-glycosidic 
linkage of core oligosaccharides to aspar- 
agine residues (Struck and Lennarz, 197’7; 
Waechter and Lennarz, 1976). Norrild and 
Pedersen (1982) recently reported that cells 
infected in the presence of tunicamycin 
contain one underglycosylated form of 
glycoprotein gC in the plasma membrane, 
a finding not confirmed by Peake et al. 
(1982). Cell fusion by syncytial forming 
mutants of HSV is also inhibited (Pizer et 
al., 1980). Compadelli-Fiume et al. (1980) 
reported that the glycosylation inhibitor 
benhydrazone caused the accumulation of 
a glycoprotein intermediate with an ap- 
parent molecular weight identical to gA 
with the concomitant loss of gB. Again, no 
infectious virus or virus-induced cell fu- 
sion occurred in the presence of this in- 
hibitor. Inhibitors of Golgi functions such 
as monensin prevent Golgi-associated oli- 
gosaccharide chain elongation, but not core 
glycosylation associated with the rough 
endoplasmic reticulum (Tartakoff and 
Vassalli, 1977, 1978). Monensin treatment 
reduces but does not prevent the produc- 
tion of infectious enveloped virus (Johnson 
and Spear, 1982), suggesting that core gly- 
cosylation is sufficient for the production 
of functional glycoproteins. 
Our laboratory has been studying the 
contribution of the carbohydrate portion 
of the HSV glycoproteins to glycopeptide 
processing, transport, and antigenicity. In 
this report, we describe the effects of the 
glycosylation inhibitor 2-deoxy-D-glucose 
on the transport of partially glycosylated 
forms of the HSV glycoproteins to the cell 
surface membrane and on the ability of 
these forms to retain antibody combining 
sites. Partially glycosylated forms anti- 
genitally related to mature glycoprotein 
species gC, gB, and gD were identified. The 
partially glycosylated forms of gC and gD 
were shown to combine with cytolytic an- 
tibody at the infected cell surface and sen- 
sitize the cell to complement-mediated 
cytolysis. The immunogenicity of the 
partially glycosylated glycoproteins was 
demonstrated by their ability to induce 
high titers of neutralizing and cytolytic 
antibody in mice immunized with synge- 
neic cells infected with HSV in the pres- 
ence of 2-deoxy-D-glucose. 
MATERIALS AND METHODS 
Cells and virus. Human embryonic lung 
(HEL) and mouse 3T3 cells were grown 
and maintained in Eagle’s minimum es- 
sential medium, MEM (GIBCO Laborato- 
ries, Grand Island, N. Y.), nonessential 
amino acids, and 10% heat-inactivated fe- 
tal calf serum (GIBCO). Wild-type HSV-1 
(KOS) and mutant syn LD70 virus were 
grown in African green monkey kidney 
(Vero) cells and titered as plaque-forming 
units (PFU) by standard plaque assays in 
Vero cells (Glorioso et al., 1980). The syn- 
cytial mutant, syn LD70, was isolated from 
the KOS strain in this laboratory (Sandri- 
Goldin et al., 1981). Syn LD70 does not 
complement the mutant MP of HSV-1, 
strain mP (Sandri-Goldin et al., 1981; Ru- 
yechan et al., 1979) and fails to synthesize 
glycoprotein C (see Results). 
Antisera. HSV-1 (KOS) rabbit antisera 
were obtained by intramuscular injection 
of New Zealand White rabbits with KOS- 
infected primary rabbit kidney cells (uv- 
inactivated) in complete Freund’s adju- 
vant (GIBCO), as described previously 
(Smith and Glorioso, 1976). Also used in 
these studies were three rabbit antisera 
monospecific for the individual HSV-1 gly- 
coproteins gC, gB, and gD. Antisera spe- 
cific for gC and gB were kindly provided 
by Dr. Richard Courtney, and the gD spe- 
cific serum by Dr. Gary Cohen. All anti- 
sera neutralized HSV-1 (KOS) in the pres- 
ence of rabbit complement. 
Mouse antisera directed against HSV-1 
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were produced in lOO- to 200-day-old 
BALB/c mice (Charles River Breeding 
Laboratories, Wilmington, Mass.) against 
both live virus and virus-infected synge- 
neic cells (uv-inactivated). For production 
of antisera against live virus, ten mice were 
each infected by intraperitoneal injection 
of 2 X lo7 PFU, a sublethal dose which all 
animals survived. For production of an- 
tisera against cells infected with wild-type 
HSV-1 (KOS), 3T3 cells were infected at 
an m.o.i. of 10 and harvested at 18 hr post- 
infection. 3T3 cells infected in the presence 
of 10 mM2-deoxy-D-glucose (Sigma Chem- 
ical Co., St. Louis, MO.) were also used as 
immunogens. The infected cells were 
washed twice in Dulbecco’s phosphate- 
buffered saline (PBS), pH 7.0, and a l-ml 
suspension of cells was uv-irradiated in an 
open 60-mm2 petri dish on a rotary shaker 
for 20 min at a distance of 10 cm using a 
uv light source (Westinghouse Sterilamp, 
Type WL-15). Groups of 10 mice were in- 
jected intraperitoneally with lo7 infected 
cells in 0.5 ml complete Freund’s adjuvant. 
The groups of mice were bled retroorbi- 
tally on Day 15 postinoculation. Sera were 
pooled and stored at -70°C. Samples were 
heat inactivated prior to use. Monoclonal 
antibodies C3, Bl, and Dl directed against 
HSV-1 glycoproteins gC, gB, and gD, re- 
spectively, were produced and character- 
ized as described by Holland et al. (1982). 
Inhibition of glycosylatim with Z-deoxy- 
Dglucose. After 1 hr for adsorption, in- 
fected cell monolayers were overlayed with 
medium containing 10 mM 2-deoxy-D-glu- 
case. The inhibitors were present for the 
duration of the infection. 
Radioiodination of viral cell surface an- 
tigens, intrinsic radiolabeling of viral pro- 
teins, and immunoprecipitation of viral an- 
tigens. Virus-induced cell surface antigens 
were radiolabeled with ‘%I as follows. 
Monolayers of lo7 HEL cells were infected 
at a multiplicity of 10 PFU/cell. At 18 hr 
after infection, the medium was decanted 
and the monolayers washed twice with PBS 
and once with PBS plus 5 mM P-D-glucose. 
Each monolayer received 1 ml ‘%I (as NaI, 
Amersham/Searle, Arlington Heights, Ill.) 
at a concentration of 0.4 mCi/ml in PBS 
containing 5 mM P-D-glucose, 0.1 ml glu- 
cose oxidase (0.25 mg/ml, Worthington 
Biochem., Freehold, N. J.), and 0.1 ml lac- 
toperoxidase (1 mg/ml in PBS, Sigma, St. 
Louis, MO.). Monolayers were incubated at 
room temperature for 15 min. The reaction 
was stopped by rinsing the monolayer once 
with PBS and twice with PBI (PBS with 
20.55 g/liter NaI substituted for the 8 g/ 
liter NaCl normally present in PBS). 
Intrinsic radiolabeling of infected cell 
proteins was carried out as follows. HEL 
cell monolayers (1 X lo7 cells) were in- 
fected with virus at a multiplicity of 10 
PFU/cell. After adsorption for 1 hr, the 
monolayer was overlaid with 5 ml MEM 
plus 2% fetal calf serum and incubated at 
37°C. Four hours after infection, the me- 
dium was replaced with 5 ml MEM con- 
taining either 2 &i/ml [14C]glucosamine, 
2 &i/ml [3H]mannose, or 5 &i/ml [35S]- 
methionine (Amersham/Searle). Twenty- 
four hours after infection, the medium was 
aspirated and 0.1 ml lysis buffer (PBS, pH 
7.4, plus 1% Nonidet P-40, and 0.1 mM 
phenylmethylsulfonyl fluoride) containing 
5 pg/ml micrococcal nuclease (Sigma) was 
added to the cells followed by incubation 
at 37°C for 15 min. The lysate was mixed 
with 0.1 ml 2X electrophoresis sample so- 
lution (ESS, 2% sodium dodecyl sulfate 
(SDS), 5% 2-mercaptoethanol, 10 mM Tris, 
10% sucrose, 1 mg/ml bromophenol blue, 
pH 7.0) and the lysates stored at -20°C. 
Prior to SDS-polyacrylamide gel electro- 
phoresis, samples were heated at 100°C for 
2 min. 
For immunoprecipitation, radiolabeled 
monolayers of cells were scraped into PBS, 
pelleted, and disrupted by resuspension of 
the pellet in 1 ml lysis buffer. Viscosity 
was decreased by addition of 50 ~1 micro- 
coccal nuclease (0.1 mg/ml, Sigma) fol- 
lowed by incubation at 37°C for 15 min. 
Debris was removed by two successive cen- 
trifugations (2000 g for 15 min followed by 
15,000 g for 15 min). Viral antigens were 
complexed with antibody by the addition 
of 20 ~1 HSV-1 (KOS) specific rabbit an- 
tiserum to the supernatant followed by in- 
cubation on ice for 1 hr. Antigen-antibody 
complexes were recovered by the addition 
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of 0.2 ml 40% (v/v) protein A-Sepharose 
CL-4B beads (Pharmacia, Piscataway, 
N. J.) in lysis buffer plus 20% sucrose, fol- 
lowed by incubation on ice for 30 min. The 
beads were washed three times with lysis 
buffer, resuspended in 100 ~1 2X ESS for 
a final protein concentration of approxi- 
mately 1 mg/ml, and frozen. Prior to SDS- 
polyacrylamide gel electrophoresis, the 
sample was heated to 100°C for 2 min and 
the beads were removed by centrifugation 
at 1000 g for 5 min. 
Polyacrylamide gel electrophoresis. Pro- 
tein samples were analyzed by SDS-poly- 
acrylamide gel electrophoresis using the 
buffer system of Laemmli (1970). Acryl- 
amide gels (10%) were crosslinked with 
N,iV’-diallyltartardiamide (Bio-Rad Lab- 
oratories, Richmond, Calif.) as described 
previously (Glorioso et al., 1980). Electro- 
phoresis of 30-~1 samples was carried out 
at a constant current of 25 mA/gel. The 
gels were fixed in 10% methanol plus 7.5% 
acetic acid, then treated with 1.0 M sodium 
salicylate in 0.1 M Tris to provide fluoro- 
graphic enhancement. Fluorographs of the 
dried gels were made on XR-5 film (Kodak, 
Rochester, N. Y.) exposed at -70°C. Es- 
timation of molecular weights was made 
by the method of Weber and Osborn (1969), 
using a Pharmacia protein standards cal- 
ibration kit. 
“Cr-Release assay for immune cytolysis. 
Monolayers of HEL cells grown in 150-cm2 
flasks were infected with wild-type HSV- 
1 (KOS) or mutant syn LD70 at an m.o.i. 
of 10. After allowing the virus to absorb 
for 1 hr, the monolayer was rinsed with 
PBS and overlaid with 10 ml MEM-2 plus 
1 mCi 51Cr (as sodium chromate; Amer- 
sham/Searle) with or without the addition 
of 10 mM2-deoxy-D-glucose. At 18 hr post- 
infection, the cells were trypsinized and 
washed four times in MEM-2. The cells 
were resuspended at a concentration of 
2 X lo5 cells/ml in MEM-2 containing 10% 
normal rabbit serum as a complement 
source. Cells used in these experiments 
were always at least 95% viable as assayed 
by trypan blue dye exclusion. One-hundred 
microliters of cell suspension (2 X lo4 cells) 
was added to three replicate wells of a 96- 
well plate followed by an equal volume of 
serially diluted antisera. The plates were 
incubated for 3 hr at 37°C. After incuba- 
tion, the plates were centrifuged at 1000 g 
and 51Cr release was measured by counting 
a lOO-~1 sample of supernatant fluid from 
each well in a gamma counter. Controls 
for each experiment included wells incu- 
bated with normal mouse serum plus com- 
plement (minimum release) and counts 
made from wells treated with 100 ~1 1 N 
HCl (maximum release). The following 
formula was used to calculate the per- 
centage specific 51Cr release: percentage 
release = (mean test cpm - mean mini- 
mum cpm)/(mean maximum cpm - mean 
minimum cpm) X 100. The 50% endpoint 
titer was taken as the dilution giving one- 
half maximum percentage 51Cr release. 
Virus neutralization. Mouse antisera 
were assayed for neutralization of HSV-1 
(KOS) in the presence and absence of com- 
plement. Doubling dilutions of antisera 
were carried out in 96-well microtiter 
plates (Linbro, Hamden, Conn.) such that 
the final volume was 50 ~1 per well. Fifty 
microliters of MEM plus 2% fetal bovine 
serum (MEM-2) containing lo4 PFU KOS 
virus was added to each serum dilution and 
the plates were incubated at 37°C for 1 hr. 
In assays involving complement-enhanced 
neutralization, the virus was diluted in 
MEM-2 plus 20% normal rabbit serum 
as a complement source. Subsequently, 
3 X lo4 Vero cells in 100 ~1 of MEM-2 were 
added to each test well and cells were al- 
lowed to attach by further incubation at 
37°C for 48 hr. After incubation, wells con- 
taining active virus showed cytopathic ef- 
fect, whereas uninfected cells appeared as 
normal monolayers. The wells were rinsed 
once with PBS and the cell monolayers 
stained with 1% crystal violet in 50% 
ethanol. The neutralization titer was ex- 
pressed as the last dilution of antibody that 
inhibited cytopathic effect by at least 50%. 
Cell controls consisted of wells in which 
only Vero cells were added with and with- 
out antiserum, and virus controls con- 
sisted of Vero cells plus virus without an- 
tiserum. Similar controls were performed 
in the presence of complement. 
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FIG. 1. Immunoprecipitation of HSV-1 proteins from 
cells infected in the presence and absence of 2-deoxy- 
D-ghCOSe. HEL cells were infected with wild-type vi- 
rus or mock infected in the presence (+) or absence 
(p) of 10 mM 2-deoxy-n-glucose and were radiola- 
beled with rJ5Slmethionine from 4 to 24 hr after in- 
fection. Viral proteins from infected cell lysates were 
immunoprecipitated with HSV-1 (KOS) specific rab- 
bit antibody. Immunoprecipitated proteins were elec- 
trophoresed in 10% SDS-polyacrylamide gels and the 
proteins were visualized by fluorography. Molecular 
weights (X10m3) are shown on the right. 
RESULTS 
Efect of Z-Deoxy-o-Glucose on the Matu- 
ratio of Viral Glycoproteim and Their 
Transport to the Cell Surface 
The mature forms of the glycoproteins 
are not synthesized in cells infected with 
HSV-1 in the presence of 2-deoxy-D-glu- 
case (Courtney, 1976; Knowles and Person, 
1976). Rather, lower-molecular-weight 
protein species are observed. However, 
their relationship to the mature glycopro- 
teins has not yet been determined. We ini- 
tiated experiments to confirm earlier find- 
ings and to examine the antigenic rela- 
tionships between these polypeptides and 
the mature virus-specified glycoproteins. 
HEL cells infected with HSV-1 (KOS) 
in the presence and absence of 2deoxy-D- 
glucose were metabolically radiolabeled 
with [35S]methionine and viral antigens 
were immunoprecipitated from extracts of 
these infected cells with hyperimmune 
rabbit anti-HSV-1 specific antibody. The 
immunoprecipitates were electrophoresed 
in polyacrylamide gels and the resulting 
autoradiogram profiles are shown in Fig. 
1. In the absence of inhibition, the major 
glycoprotein region, containing gC and gA/ 
gB (average apparent M, 123k) was de- 
tected, as well as a protein band having 
an apparent M,. comparable to gD (58k) 
(lane 3). The major capsid protein, ICP 154 
(Heine et al., 1974; Spear and Roizman, 
1972), also was precipitated. This result is 
typical of that found with hyperimmune 
rabbit antisera (J. Glorioso, unpublished 
observations). In the presence of 2-deoxy- 
D-glucose (lane 4), the 123k and the 58k 
bands disappeared with the concomitant 
appearance of two new bands, a 92k and 
an 88k species. ICP 154 was again immu- 
noprecipitated from lysates of inhibitor- 
treated cells, but its apparent molecular 
weight remained unchanged as it is not a 
glycosylated protein. Mock-infected cells 
were almost completely unreactive with 
the rabbit antiserum (Fig. 2, lanes 1 and 
2), supporting the presumption that the 
protein bands immunoprecipitated from 
virus-infected cells were virus specified. 
Comparable results also were achieved us- 
ing mouse antisera against HSV-l-in- 
fected syngeneic cells or against live virus. 
A broad radiolabeled band migrating 
with the 92k and 88k protein species could 
be detected in extracts of cells infected in 
the presence of radiolabeled [14C]glu- 
cosamine but not [3H]mannose (data not 
shown). This demonstrated that one or 
both of these peptide bands are partially 
glycosylated and are presumably devoid of 
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FIG. 2. Comparison of [ar’S]methionine and ‘%I-labeled proteins immunopreeipitated from cells 
infected in the presence and absence of 2-deoxy-D-glucose with monospecific antisera. HEL cells 
were infected with wild-type virus in the presence (+) and absence (-) of 2-deoxy-D-glucose, and 
were radiolabeled with [?S]methionine from 4 to 24 hr after infection, or radioiodinated at 18 hr 
after infection. Viral proteins from infected cell lysates were immunoprecipitated with polyclonal 
rabbit antisera monospecific for gC (lanes l-4), gB (lanes 5-8), and gD (lanes 9-12). Immunopre- 
cipitates were electrophoresed in 10% SDS-polyacrylamide gels and the proteins were visualized 
by fluorography. I and S above the lanes represent ‘%I or [?S]methionine labeling, respectively. 
Molecular weights (X10-a) are indicated on the left. 
the mannose core. These are, thus, good 
candidates for polypeptides related to the 
fully processed glycoproteins. The nomen- 
clature, DG, followed by the apparent mo- 
lecular weight will be used to designate 
altered proteins synthesized in 2-deoxy-D- 
glucose-inhibited cells. 
Monospecific polyclonal rabbit antisera 
reactive with the individual HSV-2 gly- 
coproteins were used to examine the an- 
tigenic relatedness of the DG proteins to 
the mature glycoproteins. Monospecific 
anti-gC (Fig. 2, lane 2), anti-gB (Fig. 2, 
lane 6), and anti-gD (Fig. 2, lane 10) 
precipitated the corresponding mature 
antigens from [35S]methionine - labeled 
KOS-infected cells in the absence of 2- 
deoxy-D-glucose. In presence of the inhib- 
itor, anti-gC serum precipitated the DG88 
polypeptide (Fig. 2, lane 4), demonstrating 
its antigenic relatedness to gC. Monospe- 
cific anti-B antiserum precipitated the 
DG92 protein from the [35S]methionine-la- 
beled extracts inhibited with 2-deoxy-D- 
glucose (Fig. 2, lane 8), confirming that this 
protein is antigenically related to gB. 
However, anti-gD failed to precipitate any 
polypeptide in the molecular size range ex- 
pected for glycoprotein gD from extracts 
of [35S]methionine labeled glycosylation- 
inhibited infected cells (Fig. 2, lane 12). 
The appearance of multiple bands in the 
[35S]methionine lanes require some com- 
ment. These bands are only observed in 
autoradiograms of overexposed gels. They 
could be glycoprotein precursors and/or 
degradation products of the mature or 
partially processed glycoproteins. 
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Cells infected under the same conditions 
were subjected to cell surface radioiodi- 
nation followed by immunoprecipitation 
of extracts with the monospecific antisera 
to detect the presence of viral glycopro- 
teins on the infected cell surface. In the 
absence of Z-deoxy-D-glucose, the ra- 
dioiodinated glycoproteins gC, gB, and gD 
were readily precipitated by the corre- 
sponding antisera (Fig. 2, lanes 1, 5, and 
9, respectively). The apparent molecular 
weight of the corresponding ‘%I- and [%I- 
methionine-labeled proteins were identi- 
cal. In the presence of inhibitor, the anti- 
gC serum precipitated the partially gly- 
cosylated 88k form (Fig. 2, lane 3) and the 
anti-gD serum precipitated a polypeptide 
with an apparent M, of 53k (Fig. 2, lane 
11) from the cell surface. These findings 
confirmed the antigenic relatedness of 
DG88 to gC (130k) and established an an- 
tigenic relationship between DC53 and gD 
(58k). Very little fully processed gB and no 
DG92, the partially glycosylated form of 
gB, were observed on immunoprecipita- 
tion of radioiodinated polypeptides with 
the anti-gB serum. This was the case de- 
spite the fact that these gels were inten- 
tionally overexposed to increase the 
chances of detecting low amounts of DG92 
and that an ample supply of DG92 was 
available in the cytoplasm of the inhibited 
cells (Fig. 2, lane 8). 
Mouse monoclonal antibodies (Holland 
et al., 1982) specific for the three HSV-1 
glycoproteins gC, gB, and gD also were used 
to immunoprecipitate these antigens from 
extracts of radioiodinated cells infected in 
the presence and absence of inhibitor (data 
not shown). The results were comparable 
to those obtained with the polyclonal rab- 
bit sera, again demonstrating that DG88, 
DG92, and DG53 were antigenically re- 
lated to the mature glycoproteins gC, gB, 
and gD, respectively. Again only DG88 and 
DG53 were observed on the surface of cells 
infected in the presence of inhibitor. 
Conjirm.ution of the DG88-gC Relaticmship 
Using a gC-Negative HSV-1 Mutant 
We sought to confirm a genetic rela- 
tionship, not just the antigenic related- 
ness of DG88 with gC, through use of the 
gC-deficient mutant, syn LD70. In this case, 
cells infected in the presence of inhibitor 
should fail to produce the polypeptide gC 
and consequently fail to produce DG88. 
Mutant syn LD70 is a syncytial forming 
mutant of strain KOS that fails to com- 
pliment the syncytial mutant MP of HSV- 
1 (mP), suggesting they both sustain a le- 
sion in a locus, Cr, thought to control 
expression of gC (Ruyechan et al., 1979). 
Infections were performed in the presence 
and absence of 2-deoxy-D-glucose with the 
gC-negative mutant syn LD70. Similar in- 
fections were carried out with HSV-I 
(KOS) for purposes of comparison. The 
cells were radioiodinated for the detection 
of viral cell surface antigens. The antigens 
gC, gB, and gD were readily immunopre- 
cipitated with rabbit anti-HSV-1 antise- 
rum from extracts of radioiodinated KOS 
infected cells (Fig. 3, lane l), while only 
gB and gD were immunoprecipitated from 
syn LD70 infections (lane 7). The pheno- 
type of the syn LD70 mutant is failure to 
synthesize the gC protein. Infections were 
then performed in the presence of 2-deoxy- 
D-glucose with wild-type virus and the gC- 
negative mutant syn LD70. In the presence 
of inhibitor, both anti-HSV-1 and rabbit 
anti-gC antisera immunoprecipitated 
DG88 from KOS-infected cell extracts (Fig. 
3, lanes 2 and 6, respectively). Most telling 
was the complete absence of the DG88 pro- 
tein in syn LD70 extracts (lanes 8 and 12). 
That is, cells infected with a mutant which 
fails to express gC also did not produce 
DG88. The data establish not only an an- 
tigenic, but a genetic relationship between 
gC and the glycosylation-inhibited pro- 
tein, DG88. The absence of an undergly- 
cosylated form of gB on the cell surface 
was also evident in glycosylation inhibited 
KOS and in syn LD70 infections. 
Immune Cytolysis of Target Cells hfQCtQd 
in the PrQSQnCQ of 2-dQOXy-L+ghCOSQ 
Having established that both rabbit and 
mouse antisera can immunoprecipitate the 
mature and glycosylation-inhibited forms 
of the HSV-l-induced glycoproteins, ex- 





KOS Syn 70 
Antisera 
Anti-Kor Anti-gl Anti-gC Anti-Kos Anti -gB Anti-gC 
1 2 3 4 5 6 7 8 9 10 11 12 




2 -deoxy- D-glucose 
FIG. 3. Effect of 2-deoxy-D-glucose on cell surface glycoproteins of wild-type HSV-1 (KOS)- and 
mutant syn LD’IO-infected cells. HEL cells were infected with wild-type and mutant syn LD70 virus, 
treated in the presence of 2-deoxy-D-glucose, surface labeled with iwI, and immunoprecipitated 
with polyclonal rabbit antibodies monospecific for individual glycoproteins, as described in Fig. 2. 
Molecular weights (X1O-3) are shown to the left of the fluorographs. 
periments were undertaken to determine 
if these proteins are available on the in- 
fected cell surface as target antigens for 
cytolytic antibody. 
The susceptibility of wild-type infected 
HEL target cells to immune cytolysis was 
examined using polyclonal antiserum de- 
rived from mice inoculated with wild-type 
KOS live virus. That this serum had a high 
cytolytic titer against both normal and 2- 
deoxy-D-glucose-inhibited infected cells 
can be seen from the shapes of the serum 
dilution 51Cr-release curves in Fig. 4A and 
the 50% endpoint titers given in Table 1. 
High levels of cytolysis were achieved over 
many serum dilutions. The 50% endpoint 
of this antiserum against uninhibited KOS- 
infected target cells was 10240, while the 
same cells infected in the presence of 2- 
deoxy-D-glucose were only slightly less 
susceptible to cytolysis, the 50% endpoint 
was 6303. These data demonstrate that the 
antigens which reach the cell surface in 
the glycosylation-inhibited cells are avail- 
able to antibody and are reactive as tar- 
gets for immune cytolysis. 
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FIG. 4. Susceptibility of wild-type KOS-infected cells treated with 2-deoxy-D-glucose to comple- 
ment-mediated immune cytolysis. HEL cells infected in the presence and absence of 10 m&f 2- 
deoxy-D-glucose were tested for susceptibility to antibody dependent, complement-mediated im- 
mune cytolysis using 51Cr-release assays at 18 hr after infection. Target cells used were 2-deoxy- 
D-glucose-treated infected cells (closed circles and triangles) and untreated infected cells (open 
circles and triangles). Antisera used were mouse antiserum prepared by immunization with live 
virus (A), gC-specific monoclonal antibody (B), gB-specific monoclonal antibody (C), gD-specific 
monoclonal antibody (D, circles), and mouse polyclonal antiserum monospecific for gD (D, triangles). 
The role played by the individual gly- lysed by monoclonal anti-gB serum, giving 
coproteins in immune cytolysis can be de- a 50% endpoint of 149 (Fig. 4C, Table l), 
duced by using the monoclonal antibodies showing that the interaction of the gB- 
in cytolysis reactions. Monoclonal anti-gC specific antibody with gB on the cell sur- 
antibody was highly cytolytic for uninhib- face provides an efficient mechanism for 
ited infected cells, killing 90% of target complement fixation and cell destruction. 
cells (Fig. 4B), and gave a 50% endpoint However, target cells infected in the pres- 
of 20480. The inhibited target cells were ence of 2-deoxy-D-glucose were completely 
susceptible to cytolysis with anti-gC serum, resistant to immune cytolysis with this 
although the maximum percentage 51Cr antiserum. These findings are taken as 
release was only 60% (Fig. 4B). The di- confirming the absence of detectable quan- 
lution killing curve for inhibited cells par- tities of DG92, the gB-related polypeptide, 
alleled that of uninhibited cells and gave on the cell surface of glycosylation-inhib- 
a 50% endpoint of 5881. These results im- ited cells (Fig. 2, lane ‘7, and Fig. 3, lane 
ply that DG88, the partially glycosylated 4). The monoclonal anti-gD serum showed 
form of gC, was present on the cell surface a significant but poor killing reaction 
and provided a good target for cytolytic against both target cells (Fig. 4D, Table 
antibody. A lower density of DG88 on the 1). That gD-related polypeptides are pres- 
cell surface compared with the mature ent on the cell surface and available as 
form of gC may be responsible for the 60% targets for immunolysis was confirmed 
5’Cr release in the inhibited target cells. with rabbit polyclonal monospecific anti- 
Some 90% of uninhibited target cells were gD antibody. Uninhibited and inhibited 
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TABLE 1 
IMMUNE CYTOLYSIS OF TARGET CELLS 
Wr-labeled KOS infected 
target cells 
Antiserum 






Anti-gC 20480 5881 
Anti-gB 149 0 
Anti-gD 40 40 
Note. The data presented are the 50% endpoint 
titrations of polyclonal and monoclonal cytolytic an- 
tibody directed against HSV-1 glycoproteins when 
tested against HSV-1 (KOS)-infected HEL target cells 
in the presence and absence of 2-deoxy-D-glucose. 
target cells gave good killing curves (Fig. 
4D) and 50% endpoints of 106 and 57, re- 
spectively, with this serum. 
Immunogenicity of the Partially Glycosy- 
lated Forms of the HSV-1 Glywpro- 
teins 
The question arises as to whether 2- 
deoxy-D-glucose treatment alters the im- 
munogenicity of the glycoproteins, that is, 
whether the alterations in glycosylation 
affect the induction of cytolytic or virus- 
neutralizing antibodies. BALB/c mice were 
immunized with syngeneic 3T3 cells in- 
fected with wild-type virus in the presence 
and absence of 2-deoxy-D-glucose. The in- 
fected cells were treated with ultraviolet 
irradiation to inactivate virus before in- 
oculation. The antisera were collected 15 
days after inoculation and used in immune 
cytolysis and virus neutralization assays. 
As an immunogen, 3T3 cells infected 
with KOS virions in the presence of 2- 
deoxy-D-glucose gave a substantial but 
somewhat weaker cytolytic antibody titer 
than that induced with uninhibited cells 
(Fig. 5A, B; Table 2); 50% endpoints of 844 
vs 3880. How significant these differences 
in titer are is difficult to evaluate. It should 
be pointed out that 2-deoxy-D-glucose 
treatment has an inhibitory effect on over- 
all protein synthesis (unpublished obser- 
vations) in addition to its selective effect 
on glycosylation. Smaller amounts of an- 
tigen may have been available in the in- 
hibited cells. 
Some idea of the specificities of these 
antisera for the individual glycoproteins 
can be obtained using appropriate target 
cells in immune cytolysis assays. Mutant 
syn LD70 infected cells fail to synthesize 
gC, leaving gB and gD on the infected cell 
surface. Glycoprotein gB is not available 
for interaction with cytolytic antibody on 
2-deoxy-D-glucose-inhibited KOS-infected 
cells, leaving the immature forms of gC 
and gD on the cell surface. The undergly- 
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FIG. 5. Cytotoxic antibody activity of antisera pre- 
pared against 2-deoxy-D-glucose-treated and un- 
treated HSV-1 (KOS)-infected cells. Antisera were 
produced in mice by immunization with uv-irradiated 
syngeneic 3T3 cells infected with wild-type virus in 
the presence and absence of 10 mM 2-deoxy-o-glu- 
case. Antisera produced against untreated infected 
cells (A) and treated infected cells (B) were tested 
against the following target cells using Wr-release 
assays: KOS-infected cells (O), 2-deoxy-n-glucose- 
treated KOS-infected cells (0), mutant syz LD’IO-in- 
fected cells (A), and 2-deoxy-n-glucose-treated mu- 
tant syn LD’fO-infected cells (a). 
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TABLE 2 
~~~UNOGENI~ITY OF 2-~~0xy-~-G~ucosE INHIBITED INFECTED CELLS 
Virus target 
Wr-Labeled target cells KOS SynLD’70 
-DG +DG Complement 
Antiserum KOS SynLD70 KOS SynLD70 - + - + 
KOS 3880 557 2229 40 80 2560 166 2566 
KOS + 2-deoxy-D-glucose 844 80 640 40 40 1280 40 1280 
Note. The data presented are 50% endpoint titrations of cytolytic and neutralizing antibody contained in 
the BALB/c mouse antisera produced against syngeneic 3T3 cells infected with HSV-1 (KOS) or Syn. LD 70 
both in the presence and absence of 2-deoxy-D-glucose. 
tectable glycoproteins on the cell surface 
of mutant syn LD70 infections in the pres- 
ence of 2-deoxy-D-glucose (data not shown). 
Using these cells as targets it would ap- 
pear that the two immunogens induced an- 
tibodies specific for all three glycoproteins 
and that their relative proportions are 
roughly the same in each antiserum. In 
addition, a case can be made that the ma- 
jor share of the antibody specificity for im- 
munolysis in both sera is against gC. Both 
antisera gave significant but weak cyto- 
lytic killing curves with the mutant syn 
LD’70 glycosylation-inhibited target cells 
(Fig. 5A, B) and 50% endpoints of less than 
40 each (Table 2). Since the DG form of 
gD is the only antigen on the surface of 
these target cells, this suggests that the 
contribution of anti-gD antibodies to the 
overall cytolytic reaction is small. Using 
glycosylation-inhibited KOS-infected cells 
as targets, cells in which gB is not avail- 
able as a cytolytic antibody target, killing 
curves were found which were similar but 
slightly depressed, compared to those 
found when gB was available as a target 
(Fig. 5A, B). This is reflected in slightly 
lower 50% endpoints of 2229 and 640 as 
compared to 3880 and 844 (Table 2), sug- 
gesting that most of the cytolytic activity 
is due to gC-specific antibody. This is sup- 
ported by a much more precipitous drop 
in both killing curves and in the endpoints, 
557 and 80 when mutant syn LD70-in- 
fected cells were used as targets. Since gC 
is removed as a target in the latter in- 
stance, the remaining cytolytic activity 
must largely be directed against gB. Thus, 
the underglycosylated glycoproteins can 
act as immunogens for antibody reactive 
with both the mature and immature forms 
of the three glycoproteins in complement- 
mediated immune cytolysis reactions. 
The two sera also appear to be similar 
in virus-neutralizing activity (Table 2). The 
addition of complement enhanced neu- 
tralization by four to six log, dilutions for 
both sera. Both sera are also equally ef- 
fective against mutant syn LD70 virus 
particles suggesting that antibody specific 
for gC plays a minor role in neutralization. 
All together, these findings show that 
the partially glycosylated glycoproteins are 
capable of inducing both cytolytic and neu- 
tralizing antibody and that complete gly- 
cosylation is not a necessary requirement 
for the immunogenicity of these HSV-1 
glycoproteins. 
Immunoprecipitation with Antibody In- 
duced Against Cells Infected with HSV- 
1 (KOS) in the Presence and Absence 
of Z-deoxy-pglucose 
These antisera were tested further for 
their antigenic specificities by immuno- 
precipitation of wild-type antigens from 
extracts of radioiodinated infected cells. 
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As expected, the serum produced against 
untreated wild-type infected cells precip- 
itated gC, gB, and gD (Fig. 6, lane 1). From 
the relative intensities of the bands the 
major share of the antibody is specific for 
gB. The serum produced against 2-deoxy- 
D-glucose-treated infected cells gave a 
weak precipitating reaction only with gB 
(Fig. 6, lane 2). 
DISCUSSION 
HSV-l-infected cells exhibit the virus- 
specified glycoprotein antigens gC, gB, and 
gD on the infected cell surface membrane 
(Spear, 1976). Cells infected in the pres- 
ence of the glycosylation inhibitor 2-deoxy- 
D-glucose do not synthesize the mature 
forms of the glycoproteins. Rather, lower- 
molecular-weight polypeptides accumu- 
late (Courtney, 1976; Knowles and Person, 
1976; Glorioso et al., 1980) which are an- 
tigenically related to the mature forms. In 
this report, immunoprecipitations em- 
ploying antisera specific for the individual 
HSV glycoproteins established that gC 
contains antigenic sites cross-reactive with 
the underglycosylated polypeptide DG88, 
that gB is antigenically related to DG92 
and that gD is antigenically related to 
DG53. The supposition that these proteins 
are underglycosylated forms related to the 
mature glycoproteins is strengthened by 
the demonstration of a genetic relation- 
ship between gC and DG88. 
Cell surface radiolabeling, in combina- 
tion with specific immunoprecipitation, 
demonstrated that the glycosylation in- 
hibitor differentially affected the presen- 
tation of the viral glycoproteins on the cell 
surface membrane. The peptides antigen- 
ically related to gC were the predominant 
species on the cell surface, while smaller 
amounts of a gD-related polypeptide were 
observed. Underglycosylated forms of gB 
were readily immunoprecipitated from cy- 
toplasmic extracts, but these forms were 
not detected on the cell surface. Although 
the reason for this difference in transport 
is unknown, recent experiments using in- 
hibitors affecting Golgi functions indicate 
that Golgi-associated glycosylation may 
be required for the presentation of pre- 
FIG. 6. Specificity of antisera produced against cells 
infected with wild-type virus in the presence and ab- 
sence of 2-deoxy-D-glucose. Antisera were prepared 
as described in Fig. 5. Wild-type infected HEL cells 
were radioiodinated at 18 hr after infection. Viral 
proteins were immunoprecipitated from cell lysates 
with antisera produced against untreated infected 
cells (lane 1) and treated infected cells (lane 2), elec- 
trophoresed on a 10% SDS-polyacrylamide gel, and 
visualized by autoradiography. Molecular weights 
(X10-a) are indicated on the left, and the positions of 
the glycoproteins on the right. 
cursors of gC, gB, and gD on the cell sur- 
face (Johnson and Spear, 1982). Moreover, 
gC appears to contain both N-linked and 
O-linked carbohydrate (Olofsson et al., 
1981a). Glycosylation at O-linked sites re- 
quires the addition of N-acetylgalactosa- 
mine and does not contain a mannose core. 
Thus, it is unlikely that 2-deoxy-D-glucose 
affects glycosylation and chain elongation 
at the O-linked positions. These findings 
suggest that the differential expression of 
DG92 and DG88 on the cell surface relates 
to the presence of O-linked sugars on DG88 
and that Golgi-related processing is a pre- 
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requisite for sorting of HSV glycopeptides 
to the plasma membrane. Alternatively, 
the underglycosylated form of gB may 
simply aggregate in the cytoplasm and, 
thus, lack the conformation needed for in- 
sertion into the cell surface membrane. 
The HSV glycoproteins are transported 
to the cell surface independently of one 
another. The absence of gC on the cell sur- 
face of mutant syn LD’IO-infected cells did 
not adversely affect the transport of gB 
and gD. Similarly, the absence of gB on 
the cell surface in glycosylation inhibited 
wild-type HSV-1 (KOS) infections did not 
prevent the transport of immature forms 
of gC and gD to the cell surface. In gly- 
cosylation-inhibited mutant syn LD70 in- 
fections, immature gD is transported to 
the cell surface in the absence of both gC 
and gB. It is also clear from these findings 
that complete glycosylation is not a pre- 
requisite for transport of some of the HSV 
glycoproteins, in particular gC and gD, to 
the cell surface membrane. 
Courtney et al. (1973) demonstrated that 
radiolabeled Z-deoxy-D-glucose becomes 
incorporated into the glycopeptide, ex- 
cluding the mannosyl residues which nor- 
mally attach en bloc as the mannose-rich 
core. Instead of the HSV-l-induced major 
glycoprotein region, containing primarily 
gC and gA/gB, Courtney (1976) detected a 
peptide band designated DG92 and a 
slightly faster migrating species referred 
to as VP123’. Our immunoprecipitation 
studies using monospecific antibodies 
showed that DG92 was antigenically re- 
lated to gB while DG88 was related to gC. 
The DG92 species detected in this and the 
Courtney (1976) report probably refer to 
the same gB-related antigen and VP123’ 
may be the same species as DG88. Knowles 
and Person (1976) have reported the ac- 
cumulation of three polypeptide bands in 
2-deoxy-D-glucose-treated HSV-l-infected 
cells which were designated A, B, and C. 
Based on the migration in SDS-polyacryl- 
amide gels, proteins A and B may be re- 
lated to DG92 and band C may be similar 
to DG88. 
A 58k polypeptide was immunoprecipi- 
tated with anti-HSV-1 (KOS) antiserum 
and also comes down with monoclonal an- 
tibody specific for glycoprotein D from both 
metabolically and cell surface-labeled ex- 
tracts of wild-type and mutant syn LD70 
virus-infected cells. In the presence of 2- 
deoxy-D-glucose, the 58k species is not 
found, while the partially glycosylated 
form of gD, DG53, could be detected on the 
surface membranes of infected cells. This 
gD-related form was present in low 
amounts compared to DG88, the immature 
form of gC. The gD polypeptide was not 
found in cytoplasmic extracts of glycosy- 
lation-inhibited cells with any consis- 
tency. These observations suggest that the 
gD-related polypeptides are unstable in the 
cytoplasm and may be degraded in the ab- 
sence of the carbohydrate side chains nor- 
mally attached to the polypeptides, as is 
the case for other glycoproteins (Olden et 
al., 1978; Schwartz et al., 1976). Oligosac- 
charide branch chains on glycoproteins 
may protect them from proteolytic reac- 
tions (Blobel and Dobberstein, 1975). DG53 
may be similar to pgD(52) (Pizer et al., 
1980), a partially glycosylated intermedi- 
ate of gD(58). 
Earlier work demonstrated the neces- 
sity for the expression of viral gene prod- 
ucts during infection by syncytial variants 
of HSV for the occurrence of cell fusion 
(Manservigi et al., 1977). Although virus- 
encoded proteins directly responsible for 
the induction of fusion have not yet been 
identified with certainty, glycoprotein B 
has been implicated in this process in cells 
infected with HSV-1 mutants (Haffey and 
Spear, 1980). In the presence of Z-deoxy- 
D-glucose, mutant syn LD’IO-infected cells 
no longer formed syncytia (J. Glorioso, un- 
published observation), confirming earlier 
reports for other syncytial forming vari- 
ants of HSV (Knowles and Person, 1976). 
Knowles and Person (1976) suggested that 
fully processed glycoproteins or at least 
fully processed gB, are needed for syncytia 
formation. As reported here, gB is not 
found on the cell surface in the presence 
of glycosylation inhibitors. Thus, the fail- 
ure to induce fusion may be due to the 
absence of the fusion molecule on the cell 
surface rather than the absence of car- 
bohydrate on the polypeptide. 
Pizer et al. (1980) reported on the effects 
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of tunicamycin on HSV replication, pro- 
viding evidence that viral glycoprotein 
synthesis is inhibited. They detected an 85k 
protein synthesized in the presence of tu- 
nicamycin. Peake et al. (1982) confirmed 
that the 85k polypeptide was an analog of 
pgC. However, they reported that viral an- 
tigens could not be detected on the surface 
membranes of tunicamycin inhibited in- 
fections. In contrast, Norrild and Pedersen 
(1982) reported that underglycosylated 
forms of gC and gD were present on the 
plasma membrane of tunicamycin-inhib- 
ited HSV-infected cells, although the gD- 
related form was only observed in trace 
amounts. These latter findings are similar 
to those observed in the present study us- 
ing the glycosylation inhibitor 2-deoxy-D- 
glucose. Moreover, underglycosylated 
forms of the glycoproteins antigenically 
related to gC and gD but not gB were iden- 
tified on the surface membrane of cells in- 
fected with HSV-1 (KOS) in the presence 
of tunicamycin, supporting the findings of 
Norrild and Pedersen (1982) (J. Glorioso, 
unpublished observations). 
Complement-mediated immune cytoly- 
sis provides another measure of the cell 
surface location of antigens. Cytolysis as- 
says, using mouse polyclonal and mono- 
clonal antisera, give results corroborating 
the immunoprecipitation studies. All three 
glycoproteins are reactive on the surface 
of uninhibited infected cells with mono- 
specific antibodies, confirming the findings 
of Norrild et al. (1979) that gC, gB, and gD 
can function independently as cytolytic 
targets in immunolysis assays. Antibody 
specific for gC and gD sensitized glycosy- 
lation-inhibited infected cells to immu- 
nolysis, confirming the transport and in- 
corporation on the cell surface of antigen- 
ically active DG88 and DG53, immature 
forms of gC and gD. Anti-gB antibody 
failed to lyse these cells, in correlation with 
the absence on the cell surface of DG92, 
the underglycosylated form of gB. It ap- 
pears that complete glycosylation is not a 
prerequisite for transport of gC and gD to 
the cell surface or for the preservation of 
antigenic determinants on these proteins 
recognized by cytolytic antibody. 
In contrast to these observations on 
antibody-dependent complement-mediated 
immune cytolysis, Norrild and Pedersen 
(1982) reported that antibody specific for 
gC and gB did not sensitize tunicamycin- 
treated HSV-infected cells to antibody-de- 
pendent cell-mediated immunolysis while 
antibody specific for gD gave only highly 
reduced amounts of cytolysis compared 
with uninhibited infected cells. These con- 
trasting results may relate to the different 
inhibitors used in the two studies or to the 
different mechanisms of immune cytolysis 
employed. In both our study and in that 
of Norrild and Pedersen, at least some an- 
tigenic determinants reactive with precip- 
itative antibodies were conserved in the 
underglycosylated forms of the major gly- 
coproteins. The preservation of antigenic- 
ity in underglycosylated glycoproteins was 
also borne out by the fact that carbohy- 
drate-deficient HSV-1 glycoproteins in 2- 
deoxy-D-glucose-treated infected 3T3 cells 
proved to be highly immunogenic, induc- 
ing the synthesis of cytolytic and neu- 
tralizing antibody. 
Manipulations of the target cells by 
treatment with 2-deoxy-D-glucose or by 
infection with mutant syn LD70 virus 
makes it possible to present different sub- 
sets of the glycoproteins as targets. This 
permitted an analysis of the cytolytic an- 
tibody activities directed against the in- 
dividual glycoproteins in antisera derived 
from immunizations involving untreated 
and glycosylation-inhibited infected cells. 
The data show that the relative cytolytic 
antibody specificities of the two sera are 
similar. The infected cells induce cytolytic 
antibody against each of the three anti- 
gens. The major cytolytic antibody activ- 
ity appears to be directed against gC, a 
minor portion against gD, and the re- 
mainder against gB. In contrast, anti-gC 
antibody appears not to play a critical role 
in virus neutralization. Progeny virions 
from mutant syn LD70 infection, which 
presumably have no gC in their envelopes, 
are as sensitive to neutralization by both 
antisera as are the progeny of wild-type 
KOS infections. Glycoproteins gB and gD 
appear to play a more central role in viral 
neutralization (Cohen et al., 1978; Vester- 
gaard, 1980) and both these antisera have 
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about equivalent amounts of neutralizing 
antibody specific for these glycoproteins. 
The neutralizing activity of both sera was 
greatly enhanced by complement, indicat- 
ing that the difference in specificity be- 
tween the neutralizing and cytolytic ac- 
tivities is not a consequence of differences 
in ability to fix complement. 
In contrast to relatively good cytolytic 
and neutralizing activities, the serum in- 
duced by immunization with 2-deoxy-D- 
glucose inhibited cells appears to have poor 
immunoprecipitating activity. The major 
specificity of the precipitating activity of 
both sera is against gB, while the cytolytic 
activity is primarily against gC. Both an- 
tisera have equally good virus-neutraliz- 
ing activity, in which anti-gC antibody 
plays a minor role. Thus, these three tests 
of antibody activity, immune cytolysis, vi- 
rus neutralization, and immunoprecipita- 
tion, fail to correlate with each other qual- 
itatively and quantitatively. These find- 
ings suggest that different populations of 
antibodies in the same serum carry out 
these different functions. 
In summary, evidence is presented that 
the underglycosylated forms of the HSV- 
1 glycoproteins retain both antigenicity 
and immunogenicity, suggesting that many 
of the antigenic sites are localized within 
the polypeptide backbone. Although car- 
bohydrate does not appear to be essential 
for maintenance of antigenicity, it can not 
be ruled out that the carbohydrate moi- 
eties may play an important role in pro- 
tein conformation and that some antigenic 
determinant sites are formed as a conse- 
quence of protein secondary structure. 
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